PTC Therapeutics, Inc. PTCT 深 沪
等待开盘 07-02 09:30:00 美东时间
81.35
-0.220
-0.27%
华盛通- 最 高82.785
- 今 开82.50
- 成交量 122.16万股
- 最 低 81.00
- 昨 收 81.57
- 总市值 67.48亿
- 52周最高 87.50
- 市盈率 静 10.46
- 换手率 1.47%
- 52周最低 43.175
- 委 比 52.76%
- 总股本 8294.93万
- 历史最高 87.50
- 量 比 0.38
- 振 幅 2.19%
- 历史最低 4.03
- 每 手 1
- 风险率 10.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多疾病修饰疗法取得进展 亨廷顿病市场预计2026至2036年预测期内将实现显著增长 复合年增长率达14%
DelveInsight发布2022-2036年亨廷顿舞蹈症市场洞察报告，覆盖7大核心市场（美国、欧盟四国、英国、日本）。 核心市场关键数据： 2025年7大...
06-25 22:42
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WARREN, N.J., June 17, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 11, 2026, the company approved non-statutory stock options to purchase an aggre...
06-18 04:30
PTC Therapeutics prices convertible notes for refinancing
PTC Therapeutics (PTCT) priced a private offering of $500M aggregate principal amount of 0% convertible senior notes due 2031, with an option for initial purchasers to buy an additional $50M of notes....
06-16 16:38
PTC Therapeutics Announces Proposed Private Placement Of $500M Of Convertible Senior Notes Due 2031
PTC intends to grant the initial purchasers an option to purchase, within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to $50.0 million of additional Notes. The Notes will be general senior unsecured obligations of PTC and will accrue interest payabl...
06-15 19:15
PTC Therapeutics Announces Proposed Convertible Notes Offering to Refinance 2026 Convertible Notes
– Proceeds to be used to repurchase or repay 2026 convertible notes prior to or at maturity – – Offering to include buyback of common stock – WARREN, N.J., June 15, 2026 /PRNewswire/ -- PTC ...
06-15 19:00
PTC Therapeutics Director Resigns, Moves to Advisory Role
PTC Therapeutics ( ($PTCT) ) has provided an announcement. On June 8, 2026, PTC...
06-10 06:53
美股大行评级 | 潜在涨幅99.91%！Tigress Financial上调英伟达目标价至425美元，维持"强力买入"评级
今日重点评级关注：Tigress Financial：维持英伟达"强力买入"评级，目标价从360美元升至425美元；康托·菲茨杰拉德：维持DeFi Development"超配"评级，目标价从6美元升至7美元
05-28 19:00
PTC Therapeutics upgraded at Jefferies on Sephience
Shares of PTC Therapeutics (PTCT) ended a three-day decline on Wednesday after Jefferies upgraded the stock to Buy from Hold, expecting the rare disease drugmaker to beat consensus estimates thanks to...
05-28 01:06
Jefferies Upgrades PTC Therapeutics to Buy, Raises Price Target to $85
Jefferies analyst Faisal Khurshid upgrades PTC Therapeutics (NASDAQ:PTCT) from Hold to Buy and raises the price target from $76 to $85.
05-27 23:56
美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
